Champions Oncology, Inc.

CSBRNASDAQUSD
5.87 USD
0.17 (2.90%)AT CLOSE (11:59 AM EDT)
5.84
0.03 (0.43%)
POST MARKET (AS OF 04:11 PM EDT)
Post Market
AS OF 04:11 PM EDT
5.84
0.03 (0.43%)
🔴Market: CLOSED
Open?$6.04
High?$6.04
Low?$5.80
Prev. Close?$6.04
Volume?1.5K
Avg. Volume?9.3K
VWAP?$5.89
Rel. Volume?0.16x
Bid / Ask
Bid?$5.68 × 100
Ask?$10.00 × 500
Spread?$4.32
Midpoint?$7.84
Valuation & Ratios
Market Cap?81.5M
Shares Out?13.9M
Float?5.1M
Float %?36.4%
P/E Ratio?N/A
P/B Ratio?19.03
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.98Weak
Quick Ratio?0.98Weak
Cash Ratio?0.34Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
80/100
P/E?
N/A
P/B?
19.03HIGH
P/S?
1.41CHEAP
P/FCF?
21.4FAIR
EV/EBITDA?
-96.2CHEAP
EV/Sales?
1.28CHEAP
Returns & Efficiency
ROE?
-53.3%WEAK
ROA?
-8.0%WEAK
Cash Flow & Enterprise
FCF?$3.8M
Enterprise Value?$74.4M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Employees
306
Market Cap
81.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1994-10-31
Address
855 N. WOLFE STREET
BALTIMORE, MD 21205
Phone: 410-369-0365